AstraZeneca says Symbicort as anti-inflammatory reliever reduces attacks in mild asthma

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 21, 2019 at 10:52 AM.

  1. #1 cafead, May 21, 2019 at 10:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol) as a potential anti-inflammatory reliever in mild asthma.

    article source
     
    Quote

Reply to Thread